INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845P108 Class: Common Stock

Bellevue Group AG's Holding History (CIK: 0001674546)

Note: Option positions (PUT/CALL) are excluded.

Q1 2021
Shares 8,000 Value ($000) $185 Avg Close — Range —
Q4 2020
Shares 8,000 Value ($000) $198 Avg Close — Range —
Q3 2020
Shares 704,976 Value ($000) $29,229 Avg Close — Range —
Q2 2020
Shares 704,976 Value ($000) $33,775 Avg Close — Range —
Q1 2020
Shares 708,976 Value ($000) $44,638 Avg Close — Range —
Q4 2019
Shares 715,176 Value ($000) $88,624 Avg Close — Range —
Q3 2019
Shares 702,176 Value ($000) $46,596 Avg Close — Range —
Q2 2019
Shares 711,803 Value ($000) $56,638 Avg Close — Range —
Q1 2019
Shares 17,227 Value ($000) $1,927 Avg Close — Range —
Q4 2018
Shares 23,148 Value ($000) $2,333 Avg Close — Range —
Q3 2018
Shares 24,148 Value ($000) $3,051 Avg Close — Range —
Q2 2018
Shares 24,648 Value ($000) $2,068 Avg Close — Range —
Q1 2018
Shares 31,900 Value ($000) $1,962 Avg Close — Range —
Q4 2017
Shares 19,400 Value ($000) $1,133 Avg Close — Range —
Q3 2017
Shares 8,500 Value ($000) $493 Avg Close — Range —
Q2 2017
Shares 8,500 Value ($000) $1,029 Avg Close — Range —
Q1 2017
Shares 8,500 Value ($000) $961 Avg Close — Range —
Q4 2016
Shares 8,500 Value ($000) $924 Avg Close — Range —
Q3 2016
Shares 13,500 Value ($000) $2,222 Avg Close — Range —
Q2 2016
Shares 13,500 Value ($000) $1,926 Avg Close — Range —
Q1 2016
Shares 13,500 Value ($000) $1,734 Avg Close — Range —